USP25 and dysplasia: Interestingly, analysis of a GEO dataset (GSE30784) confirmed the findings derived from the aforementioned analysis and demonstrated that the levels of USP25 gradually decreased from normal tissues through dysplasia lesions, to carcinoma (Fig. 2F), suggesting that USP25 downregulation is an early and sustained event in malignant transformation.